National program for preventing mother–child HIV transmission in Thailand: successful implementation and lessons learned
Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57
Skeletal muscle mitochondrial function and exercise capacity in HIV-infected patients with lipodystrophy and elevated p-lactate levels
Supernatants of HIV-infected immune cells affect the barrier function of human HT-29/B6 intestinal epithelial cells
High Epstein–Barr virus (EBV) DNA loads in HIV-infected patients: correlation with antiretroviral therapy and quantitative EBV serology
Non-cytotoxic inhibition of HIV-1 infection by unstimulated CD8+ T lymphocytes from HIV-exposed-uninfected individuals
Amprenavir-resistant HIV-1 exhibits lopinavir cross-resistance and reduced replication capacity
Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy
Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults
Drug resistance at low viraemia in HIV-1-infected patients with antiretroviral combination therapy
Aseptic meningitis and optic neuritis preceding varicella-zoster progressive outer retinal necrosis in a patient with AIDS
Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up
Community study of the relative impact of HIV-1 and HIV-2 on intrathoracic tuberculosis
Prescribing practices in a population-based HIV postexposure prophylaxis program
HIV-1 Vpu represents a minor target for cytotoxic T lymphocytes in HIV-1-infection
CD4 cell count changes in individuals with counts above 500 cells/mm3 and viral loads below 50 copies/ml on antiretroviral therapy
Normalization of cytomegalovirus-specific CD4 T cells in HIV-1-infected individuals receiving antiretroviral therapy
Efficacy and safety of abacavir plus efavirenz as a salvage regimen in HIV-infected individuals after 48 weeks
The effect of AIDS on maternal mortality in Malawi and Zimbabwe
Warning: Antiretroviral treatment interruption could lead to an increased risk of HIV transmission
High rate of discontinuations of highly active antiretroviral therapy as a result of antiretroviral intolerance in clinical practice: missed opportunities for adherence support?
Switching to zidovudine plus lamivudine plus abacavir maintains viral suppression in patients with high viral load before antiretroviral therapy: a retrospective clinical cohort analysis
Lipodystrophy body-shape changes in a patient undergoing zidovudine monotherapy
Human herpesvirus 8 cytoviraemia rebound in a patient with Kaposi's sarcoma after a short interruption of efficient antiretroviral therapy